This is written in response to the previous question (Nov 18) raised, as well as to provide a brief update on the H1N1 vaccine.
"What do you feel is the most prudent/cost-effective way of spending $6 million of taxpayer's money (with regards to low H1N1 fatality and 200,000 vaccine doses set aside for essential government personnel)?"
I have been reluctant to respond, because it is clear that the answer will vary depending on one's perspective and priorities, and the circumstances at that point in time. There are many interest groups in health that will appreciate a $6 million injection - research (even though the funding has already been exceptionally generous, especially to a few focus groups), cancer care, elderly, mental health, dialysis, safety initiatives, community coverage, etc. Try to cater to all, and even $6 million starts to look rather miserly. Disburse the money to a few, and the others will inevitably wonder about priorities/favoritism.
MOH has chosen to spend this money on H1N1 vaccine doses for essential government personnel, all of whom no doubt can afford the vaccine on their own (but probably only about half who would otherwise have spontaneously gone to get themselves vaccinated). That is its prerogative, and the decision is not as bad as it has been made to look.
Now, about the inactivated H1N1 vaccine (or the various types of inactivated vaccine - they are more or less similar):
- Its efficacy in published studies is anywhere between 61% to 92%. Obviously less effective if one is older, or one's immune system is less robust. On average, the vaccine will probably not trigger off a protective response in 1 of 4 persons. These figures are similar to the usual seasonal influenza vaccines. Of course, if you have already had H1N1, there is no need to get vaccinated.
- The side effect profile is the same as seasonal influenza vaccines as well. Most people with adverse events have fever, while a rare few will have a more serious adverse event. Anywhere between 0.8 to 6 persons out of every 1,000 vaccinated will develop an adverse event. In short, the vaccine is far safer than getting H1N1.
Many doctors I know have not received the H1N1 vaccination - even though it is free for healthcare staff in the local public hospitals. There are a plethora of reasons (including convenience and work schedule issues), but the gist of it essentially boils down to this: the fear of getting a rare but serious side-effect outweighs the (higher) risk of getting a largely benign illness that one is familiar and experienced with. It is a known psychological issue, and it is not because the doctor has somehow obtained secret/unreleased knowledge about H1N1 vaccine risks.